Clinical trials
Phase 2/3 Premature Birth trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2008 | 3 |
| 2009 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Unknown status | 9 |
| Recruiting | 4 |
| Terminated | 3 |
| Withdrawn | 2 |
| Suspended | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| NICHD Neonatal Research Network | 4 |
| Obstetrix Medical Group | 3 |
| Pediatrix | 2 |
| The University of Hong Kong | 2 |
| University of Alabama at Birmingham | 2 |
| University of Washington | 2 |
| Abbott | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Assiut University | 1 |
| Baylor College of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Premature Birth | 44 |
| Bronchopulmonary Dysplasia | 6 |
| Respiratory Distress Syndrome | 4 |
| Obstetric Labor, Premature | 3 |
| Sepsis | 3 |
| Ductus Arteriosus, Patent | 2 |
| Pain | 2 |
| Anemia, Neonatal | 1 |
| Apnea | 1 |
| Blindness | 1 |
Trials
Showing 26 to 44 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.